Antibody repertoire analysis of mouse immunization protocols using microfluidics and molecular genomics

ABSTRACT Immunization of mice followed by hybridoma or B-cell screening is one of the most common antibody discovery methods used to generate therapeutic monoclonal antibody (mAb) candidates. There are a multitude of different immunization protocols that can generate an immune response in animals. However, an extensive analysis of the antibody repertoires that these alternative immunization protocols can generate has not been performed. In this study, we immunized mice that transgenically express human antibodies with either programmed cell death 1 protein or cytotoxic T-lymphocyte associated protein 4 using four different immunization protocols, and then utilized a single cell microfluidic platform to generate tissue-specific, natively paired immunoglobulin (Ig) repertoires from each method and enriched for target-specific binders using yeast single-chain variable fragment (scFv) display. We deep sequenced the scFv repertoires from both the pre-sort and post-sort libraries. All methods and both targets yielded similar oligoclonality, variable (V) and joining (J) gene usage, and divergence from germline of enriched libraries. However, there were differences between targets and/or immunization protocols for overall clonal counts, complementarity-determining region 3 (CDR3) length, and antibody/CDR3 sequence diversity. Our data suggest that, although different immunization protocols may generate a response to an antigen, performing multiple immunization protocols in parallel can yield greater Ig diversity. We conclude that modern microfluidic methods, followed by an extensive molecular genomic analysis of antibody repertoires, can be used to quickly analyze new immunization protocols or mouse platforms.

[1]  Jedd D. Wolchok,et al.  Cancer immunotherapy using checkpoint blockade , 2018, Science.

[2]  Robert C. Edgar,et al.  A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody library , 2018, mAbs.

[3]  Jonathan R. McDaniel,et al.  Functional Interrogation and Mining of Natively-Paired Human VH:VL Antibody Repertoires , 2017, Nature Biotechnology.

[4]  Robert C. Edgar,et al.  Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomics , 2017, mAbs.

[5]  R. Edgar,et al.  Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics , 2017, mAbs.

[6]  Cédric R. Weber,et al.  Systems Analysis Reveals High Genetic and Antigen-Driven Predetermination of Antibody Repertoires throughout B Cell Development. , 2017, Cell reports.

[7]  P. Diot,et al.  Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France , 2016, mAbs.

[8]  A. Ellington,et al.  Discovery of high affinity anti-ricin antibodies by B cell receptor sequencing and by yeast display of combinatorial VH:VL libraries from immunized animals , 2016, mAbs.

[9]  Shixia Wang,et al.  DNA immunization as a technology platform for monoclonal antibody induction , 2016, Emerging Microbes & Infections.

[10]  F. Hu,et al.  Expression and characterization of a Talaromyces marneffei active phospholipase B expressed in a Pichia pastoris expression system , 2016, Emerging Microbes & Infections.

[11]  J. Lunceford,et al.  Pembrolizumab for the treatment of non-small-cell lung cancer. , 2015, The New England journal of medicine.

[12]  Burak Dura,et al.  Deformability-based microfluidic cell pairing and fusion. , 2014, Lab on a chip.

[13]  T. Panavas,et al.  IgG variable region and VH CDR3 diversity in unimmunized mice analyzed by massively parallel sequencing. , 2014, Molecular immunology.

[14]  S. Quake,et al.  The promise and challenge of high-throughput sequencing of the antibody repertoire , 2014, Nature Biotechnology.

[15]  R. Scheller,et al.  An improved and robust DNA immunization method to develop antibodies against extra-cellular loops of multi-transmembrane proteins , 2014, mAbs.

[16]  Shixia Wang,et al.  Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine , 2013, Vaccines.

[17]  S. Quake,et al.  Correlation of Gene Expression and Genome Mutation in Single B-Cells , 2013, PloS one.

[18]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[19]  Stephen L. Hauser,et al.  Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation , 2011, Proceedings of the National Academy of Sciences.

[20]  J. Yewdell,et al.  MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines , 2011, Science Translational Medicine.

[21]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[22]  Robert C. Edgar,et al.  Search and clustering orders of magnitude faster than BLAST , 2010, Bioinform..

[23]  J. Reichert,et al.  Development trends for human monoclonal antibody therapeutics , 2010, Nature Reviews Drug Discovery.

[24]  Seung Hyun Kang,et al.  Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells , 2010, Nature Biotechnology.

[25]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[26]  Kevin C. Dorff,et al.  The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models , 2010, Nature Biotechnology.

[27]  R. Ward,et al.  Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus. , 1999, Vaccine.

[28]  M. Surani,et al.  A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  F. Alt,et al.  Ordered rearrangement of immunoglobulin heavy chain variable region segments. , 1984, The EMBO journal.

[30]  S. Tonegawa Somatic generation of antibody diversity , 1983, Nature.

[31]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[32]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .